Saturday - November 22, 2025

Category Archives: Pharmaceuticals & Biotech

Diabetic Macular Edema Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution

DelveInsight’s “Diabetic Macular Edema Pipeline Insight 2025” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Eczema Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution

DelveInsight’s, “Eczema Pipeline Insight, 2025” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Eczema pipeline landscape. It covers the Eczema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Eczema pipeline therapeutics … Continue reading →

Type 1 Diabetes Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution

DelveInsight’s, “Type 1 Diabetes Pipeline Insight, 2025” report provides comprehensive insights about 85+ companies and 100+ pipeline drugs in Type 1 Diabetes pipeline landscape. It covers the Type 1 Diabetes pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Acute Respiratory Distress Syndrome Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution

DelveInsight’s, “Acute Respiratory Distress Syndrome Pipeline Insights 2025” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Acute Respiratory Distress Syndrome pipeline landscape. It covers the Acute Respiratory Distress Syndrome pipeline drug profiles, including clinical and nonclinical … Continue reading →

Alzheimer’s Disease Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, and Strategic Market Evolution

DelveInsight’s, “Alzheimer’s Disease Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Alzheimer’s disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment … Continue reading →

BioLight unveils redesigned website to enhance digital experience and expand access to science-driven wellness

BioLight announces the official launch of its redesigned website, introducing a modern interface, improved navigation, and expanded educational resources focused on light-based wellness and science-driven health insights. Montana – BioLight today announced the official launch of its redesigned website, BioLight.shop, introducing … Continue reading →

Desmoid Tumors Market Set for Significant Growth Through 2034, Reveals DelveInsight | Clinical Trials, Medication, Prevalence, Companies

Desmoid Tumors Market Desmoid Tumors Companies are SpringWorks Therapeutics, Immunome/Ayala Pharmaceuticals, Iterion Therapeutics, Eisai and PRISM BioLab, MedPacto, Inc., Pfizer, Novartis, Ayala Pharmaceuticals, Iterion Therapeutics, Aadi Bioscience, Inc., INSYS Therapeutics Inc, Recursion Pharmaceuticals Inc, and others. In 2023, the desmoid … Continue reading →

Open Angle Glaucoma Clinical Trial Landscape Expands With 20+ Emerging Therapies, Reveals DelveInsight | FDA Approvals, Medication, Therapies, Companies

Open Angle Glaucoma Pipeline Open Angle Glaucoma companies are Nicox Ophthalmics, Betaliq, Inc., Qlaris Bio, Aerpio Pharmaceuticals, Theratocular Biotek, PolyActiva Pty Ltd., Whitecap Biosciences, JeniVision, EMS and others. According to DelveInsight’s analysis, the global Open-Angle Glaucoma pipeline includes more than … Continue reading →